Prolaris’ Value in Predicting Prostate Cancer Outcomes by admin_63069 | Jan 13, 2025 | News You Can Use The National Comprehensive Cancer Network (NCCN) has endorsed the Prolaris prostate cancer prognostic test, reinforcing its position as a critical tool in prostate cancer prognostication.
